These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3115904)
1. Topical mupirocin versus oral erythromycin in the treatment of primary and secondary skin infections. Gratton D Int J Dermatol; 1987 Sep; 26(7):472-3. PubMed ID: 3115904 [No Abstract] [Full Text] [Related]
2. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice. Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167 [TBL] [Abstract][Full Text] [Related]
4. Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin. Barton LL; Friedman AD; Sharkey AM; Schneller DJ; Swierkosz EM Pediatr Dermatol; 1989 Jun; 6(2):134-8. PubMed ID: 2501775 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of topical mupirocin in moderately severe primary and secondary skin infections. Buchvald J J Int Med Res; 1988; 16(1):66-70. PubMed ID: 3127257 [TBL] [Abstract][Full Text] [Related]
7. Mupirocin: a new topical antibiotic. Leyden JJ J Am Acad Dermatol; 1990 May; 22(5 Pt 1):879-83. PubMed ID: 2112165 [TBL] [Abstract][Full Text] [Related]
8. Topical mupirocin vs. systemic erythromycin treatment for pyoderma. McLinn S Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127 [TBL] [Abstract][Full Text] [Related]
9. Use of mupirocin ointment in the treatment of secondarily infected dermatoses. Breneman DL J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167 [TBL] [Abstract][Full Text] [Related]
10. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. McLinn S J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166 [TBL] [Abstract][Full Text] [Related]
12. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. Gilbert M J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection. Boon RJ; Beale AS; Sutherland R J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130 [TBL] [Abstract][Full Text] [Related]
18. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections. Odom RB Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071 [TBL] [Abstract][Full Text] [Related]
19. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections]. Colin M; Avon P Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741 [TBL] [Abstract][Full Text] [Related]
20. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Lever R; Hadley K; Downey D; Mackie R Br J Dermatol; 1988 Aug; 119(2):189-98. PubMed ID: 3139019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]